Treatment for Auricular Cellulitis
For auricular cellulitis, initiate oral antibiotics targeting β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus (MSSA) with cephalexin 500 mg every 6 hours or penicillin-based therapy for 5 days, extending treatment only if no improvement is seen within this timeframe 1.
Antibiotic Selection Algorithm
First-Line Therapy (Uncomplicated Cases)
- Oral cephalexin 500 mg every 6 hours is the preferred agent 1
- Alternative: Oral penicillin or amoxicillin for streptococcal coverage 2
- These target the most common pathogens: β-hemolytic streptococci and MSSA 2, 3
The evidence strongly supports oral therapy as equally effective as IV antibiotics for uncomplicated cellulitis. A 2015 randomized trial demonstrated oral cefalexin was non-inferior to IV cefazolin, with actually faster resolution (1.29 vs 1.78 days to cessation of advancement) 4.
When to Escalate to MRSA Coverage
Add vancomycin or another anti-MRSA agent (e.g., TMP-SMX, doxycycline) if ANY of these risk factors are present 1:
- Penetrating trauma to the auricle
- Evidence of MRSA infection elsewhere
- Nasal MRSA colonization
- Injection drug use
- Systemic inflammatory response syndrome (SIRS): fever, tachycardia, tachypnea, abnormal WBC
Severe or Complicated Infections
For patients with SIRS, hemodynamic instability, or immunocompromise, use vancomycin 15 mg/kg IV every 12 hours plus piperacillin-tazobactam or a carbapenem 1.
Treatment Duration
Treat for exactly 5 days 1. This is a firm recommendation based on high-quality evidence. Only extend beyond 5 days if the infection has not improved—do not reflexively prescribe 7-10 days as is common practice.
Hospitalization Criteria
Admit patients with 1:
- SIRS or hemodynamic instability
- Altered mental status
- Concern for deeper infection (perichondritis—see below)
- Severe immunocompromise
- Failed outpatient therapy
- Poor adherence anticipated
Otherwise, manage as outpatient with oral antibiotics.
Critical Pitfall: Distinguishing Cellulitis from Perichondritis
Auricular perichondritis is a surgical emergency that can lead to cartilage necrosis and "cauliflower ear" deformity 5. Key distinguishing features:
- Perichondritis typically follows ear piercing through cartilage, trauma, or surgery 5
- More severe pain and systemic symptoms
- Involves the cartilage itself, not just overlying skin
- Pseudomonas aeruginosa is the predominant pathogen (41.9% of cases), not streptococci 5
If perichondritis is suspected, empiric coverage must include antipseudomonal fluoroquinolones (ciprofloxacin 400 mg IV q12h or 750 mg PO q12h) or aminoglycosides, plus anti-staphylococcal coverage 5. Delayed treatment beyond 3 days significantly increases complications 5.
Adjunctive Measures
- Elevate the affected area 1
- Treat predisposing factors: trauma sites, underlying dermatologic conditions 1
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is weak 1
What NOT to Do
- Do not routinely cover MRSA in uncomplicated cases without risk factors—this contributes to resistance 2, 3
- Do not order extensive laboratory testing (CBC, CRP, ESR) for straightforward cases—cellulitis is a clinical diagnosis 2, 3
- Do not use IV antibiotics when oral therapy is appropriate—it increases cost, discomfort, and complications without improving outcomes 4
- Do not culture routine cellulitis—only 15% yield organisms and it rarely changes management 3